淡明細胞型腎細胞癌のLOXL2 によるインテグリン発現制御機構

長谷, 拓明

Number of Access:814（2025-08-16 04:45 Counts）

Identifier to cite or link to this item: https://doi.org/10.18910/34400

Link to primary information 

File Format Terms of use Size Views Date.Available Description information
26856_Dissertation pdf None 4.14 MB 839 2015.12.14 論文/Dissertation  
26856_Abstract pdf None 115 KB 680 2014.05.27 要旨/Abstract  

Item Information

Output File Export EndNote Basic Export Mendeley

Title
淡明細胞型腎細胞癌のLOXL2 によるインテグリン発現制御機構
タンメイ　サイボウガタ　ジンサイボウガン　ノ　LOXL2　ニ　ヨル　インテグリン　ハツゲン　セイギョ　キコウ
Creator
NRID
1000080779926 1000080779926
researchmap permalink
hase-h hase-h
Scopus Author ID
55360273600 55360273600
CreatorName
長谷, 拓明 ; ハセ, ヒロアキ
Description
Hiroaki Hase, Kentaro Jingushi, Yuko Ueda, Kaori Kitae, Hiroshi Egawa, Ikumi Ohshio, Ryoji Kawakami, Yuri Kashiwagi, Yohei Tsukada, Takumi Kobayashi, Wataru Nakata, Kazutoshi Fujita, Motohide Uemura, Norio Nonomura, and Kazutake Tsujikawa, LOXL2 Status Correlates with Tumor Stage and Regulates Integrin Levels to Promote Tumor Progression in ccRCC, Mol Cancer Res December 2014 12:1807-1817
Degree Name
博士（薬学）
Date of Granted
2014-03-25
Grantor
Osaka University
Faculty
薬学
Specialty
応用医療薬科学
Grant ID
甲第17022号
Description Number
26856
Language
Japanese
Handle URL
https://hdl.handle.net/11094/34400
DOI
https://doi.org/10.18910/34400
Relation.references
URI
http://mcr.aacrjournals.org/content/12/12/1807.full.pdf
Access Rights
open access
oaire:version
Version of Record
Category
Doctoral Thesis with Full Text / Graduate School of Pharmaceutical Sciences / 2013
Doctoral Thesis / Graduate School of Pharmaceutical Sciences / 2013